MedTrace Logo

Biocollection on Peripheral Inflammation

NCT05934474 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-04-08

No results posted yet for this study

Summary

Most psychiatric research is based on the nosographic classifications used in current practice. At present, there is no diagnostic or prognostic biomarker for psychiatric pathologies commonly used in clinical practice. The study hypothesis is that peripheral inflammatory biomarkers could be common to several psychiatric disorders, in particular psychotic disorders (bipolar disorder, schizophreniform disorder, schizophrenia, depressive episode with psychotic features). The aim of this project is to set up a bio-collection of biological samples (peripheral blood samples) with associated phenotypic data (assessment of various symptoms using standardized scales in patients whose blood is sampled). The setting up of this cohort follows on from work carried out on a PsyCourse cohort also using a transdiagnostic approach in psychiatry, in order to be able to collaborate within a European research project.

Conditions

  • Schizoaffective Disorder, Depressive Type
  • Bipolar Disorder I
  • Bipolar Disorder II

Interventions

BIOLOGICAL

Peripheral venipuncture blood sampling, as part of standard care procedures

Collection of 36 mL of blood

OTHER

Interview with a psychiatrist

Research project data collection

Sponsors & Collaborators

  • CR2TI, INSERM, UMR1064

    collaborator UNKNOWN

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Anne Sauvaget · Nantes University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-19
Primary Completion
2026-08-02
Completion
2028-02-02

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05934474 on ClinicalTrials.gov